Clinical trial
Quality of Life Study in Patients With Cancer Breakthrough Pain Treated in Palliative Care Units
NCT02840500 is registered in ClinicalTrials.gov with Angelini Farmacéutica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Quality of Life Study in Patients With Cancer Breakthrough Pain Treated in Palliative Care Units
- Lead sponsor
- Angelini Farmacéutica
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 27, 2016
- Completion date
- March 31, 2018
- Enrollment
- 101 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.